163 related articles for article (PubMed ID: 19103853)
21. National registry of hemoglobinopathies in Spain (REPHem).
Cela E; Bellón JM; de la Cruz M; Beléndez C; Berrueco R; Ruiz A; Elorza I; Díaz de Heredia C; Cervera A; Vallés G; Salinas JA; Coll MT; Bermúdez M; Prudencio M; Argilés B; Vecilla C;
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27804209
[TBL] [Abstract][Full Text] [Related]
22. Neonatal haemoglobinopathy screening in Belgium.
Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
[TBL] [Abstract][Full Text] [Related]
23. [Early detection of sickle cell anemia and other hemoglobinopathies in neonates in the Autonomous Community of Madrid. A pilot study].
Dulín Iñígueza E; Cantalejo López MA; Cela de Julián ME; Galarón García P
An Pediatr (Barc); 2003 Feb; 58(2):146-55. PubMed ID: 12628145
[TBL] [Abstract][Full Text] [Related]
24. Screening for haemoglobin disorders: One size may not fit all.
Shook LM; Ware RE
Br J Haematol; 2024 Jan; 204(1):26-28. PubMed ID: 37877454
[TBL] [Abstract][Full Text] [Related]
25. Neonatal haemoglobinopathy screening in Burkina Faso.
Kafando E; Nacoulma E; Ouattara Y; Ayéroué J; Cotton F; Sawadogo M; Gulbis B
J Clin Pathol; 2009 Jan; 62(1):39-41. PubMed ID: 19103858
[TBL] [Abstract][Full Text] [Related]
26. [One year of neonatal screening for sickle-cell disease in Emma Children's Hospital/Academic Medical Center in Amsterdam].
Heijboer H; van den Tweel XW; Peters M; Knuist M; Prins J; Heymans HS
Ned Tijdschr Geneeskd; 2001 Sep; 145(37):1795-9. PubMed ID: 11582643
[TBL] [Abstract][Full Text] [Related]
27. [Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England].
van Rhee MA; Holm JP; Niermeijer MF
Ned Tijdschr Geneeskd; 1998 May; 142(18):996-7. PubMed ID: 9623197
[TBL] [Abstract][Full Text] [Related]
28. Implementing neonatal screening for haemoglobinopathies in the Netherlands.
Bouva MJ; Mohrmann K; Brinkman HB; Kemper-Proper EA; Elvers B; Loeber JG; Verheul FE; Giordano PC
J Med Screen; 2010; 17(2):58-65. PubMed ID: 20660432
[TBL] [Abstract][Full Text] [Related]
29. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
[TBL] [Abstract][Full Text] [Related]
30. The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique.
Grosse SD; Olney RS; Baily MA
Appl Health Econ Health Policy; 2005; 4(4):239-47. PubMed ID: 16466275
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction].
Cela de Julián E; Dulín Iñiguez E; Guerrero Soler M; Arranz Leirado M; Galarón García P; Beléndez Bieler C; Bellón Cano JM; García Arias M; Cantalejo López A
An Pediatr (Barc); 2007 Apr; 66(4):382-6. PubMed ID: 17430715
[TBL] [Abstract][Full Text] [Related]
32. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
Brunod M
Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
[No Abstract] [Full Text] [Related]
33. Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis.
Panepinto JA; Magid D; Rewers MJ; Lane PA
J Pediatr; 2000 Feb; 136(2):201-8. PubMed ID: 10657826
[TBL] [Abstract][Full Text] [Related]
34. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
[TBL] [Abstract][Full Text] [Related]
35. Newborn screening for sickling and other haemoglobin disorders using tandem mass spectrometry: A pilot study of methodology in laboratories in England.
Daniel YA; Henthorn J
J Med Screen; 2016 Dec; 23(4):175-178. PubMed ID: 26965059
[TBL] [Abstract][Full Text] [Related]
36. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7.
Streetly A; Latinovic R; Hall K; Henthorn J
J Clin Pathol; 2009 Jan; 62(1):26-30. PubMed ID: 19103854
[TBL] [Abstract][Full Text] [Related]
37. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
38. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
Green NS; Zapfel A; Nnodu OE; Franklin P; Tubman VN; Chirande L; Kiyaga C; Chunda-Liyoka C; Awuonda B; Ohene-Frempong K; Inusa BPD; Ware RE; Odame I; Ambrose EE; Dogara LG; Oron AP; Willett C; Thompson AA; Berliner N; Coetzer TL; Novelli EM
Blood Adv; 2022 Dec; 6(24):6187-6197. PubMed ID: 36264096
[TBL] [Abstract][Full Text] [Related]
39. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
